Stock listing

BVC:JNJ Johnson & Johnson Acciones

Colombian listing (BVC) of Johnson & Johnson · home listing NYSE:JNJ

Follow Johnson & Johnson into a list and get an email when it puts out news.

Home listing price · NYSE:JNJ

$270.47 USD -2.23 (-0.8%)

Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NYSE:JNJ

Past year +33.2% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$269.47 – $272.50 USDNov 20, 2026
Volume
11.92M sharesNov 20, 2026
Market cap
$651.1B USDAt the close on Nov 20, 2026 · price × 2.41B shares outstanding
52-week range
$199.91 – $290.25 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$1.92B USDMedian day 6.45M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Johnson & Johnson logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NYSE:JNJ · Home$270.47 USD-2.23 (-0.8%)11,921,706$270.36$272.50$269.47$272.70Close on Nov 20, 2026
BCBA:JNJ$32,380 ARS+1,500 (+4.9%)15,029$31,080$32,820$31,080$30,880Close on Nov 20, 2026
Xetra:JNJ€247.00 EUR+5.00 (+2.1%)2,427€245.10€248.25€244.45€242.00Close on Nov 20, 2026
B3:JNJB34105.28 BRL-3.45 (-3.2%)4,831109.82110.00104.00108.73Close on Nov 19, 2026
BMV:JNJ$5,140.01 MXN+61.01 (+1.2%)775$5,152.91$5,160.00$5,130.00$5,079.00Close on Nov 20, 2026
Cboe Canada:JNJ$34.49 CAD+0.66 (+2.0%)5,000$34.43$34.54$34.43$33.83Close on Nov 20, 2026
Frankfurt:JNJ€246.90 EUR+4.40 (+1.8%)—€245.55€248.35€243.50€242.50Close on Nov 20, 2026
Munich:JNJ€246.40 EUR+0.25 (+0.1%)65€245.05€246.40€245.05€246.15Close on Nov 20, 2026
Hamburg:JNJ€246.85 EUR+5.75 (+2.4%)—€244.45€246.85€244.30€241.10Close on Nov 20, 2026
Dusseldorf:JNJ€246.50 EUR+3.60 (+1.5%)—€244.15€246.65€244.15€242.90Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NYSE:JNJ · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$270.47-2.23-0.8%$270.36$272.50$269.4711,921,706
$272.70-6.00-2.2%$275.55$278.72$272.587,789,258
$278.70-3.85-1.4%$278.99$281.72$277.568,051,381
$282.55-3.20-1.1%$288.99$290.25$282.337,836,938
$285.75+2.23+0.8%$285.00$288.11$281.686,130,885
$283.52+3.11+1.1%$284.38$286.08$281.007,677,364
$280.41-0.37-0.1%$277.96$281.16$276.595,436,652
$280.78-1.33-0.5%$282.00$283.25$279.197,338,513
$282.11+5.89+2.1%$278.00$282.73$276.206,894,611
$276.22+3.90+1.4%$267.56$276.41$265.558,860,834
$272.32-4.00-1.4%$278.92$281.92$271.649,641,967
$276.32+10.15+3.8%$272.41$277.35$267.679,540,249
$266.17-4.39-1.6%$268.51$271.07$265.286,453,538
$270.56-2.64-1.0%$272.06$273.01$267.448,014,235
$273.20-2.00-0.7%$280.00$282.02$273.138,948,945
$275.20+4.16+1.5%$275.31$278.05$273.605,989,828
$271.04+2.31+0.9%$265.83$272.75$264.206,396,275
$268.73+2.43+0.9%$265.25$269.09$264.835,774,670
$266.30+2.49+0.9%$266.74$272.36$264.975,734,551
$263.81-3.80-1.4%$265.82$266.03$262.405,305,727
$267.61+9.83+3.8%$260.54$269.67$259.049,711,497
$257.78-1.58-0.6%$257.50$257.80$254.566,148,851
$259.36+5.57+2.2%$257.48$260.77$256.427,634,901
$253.79-1.77-0.7%$254.43$255.56$251.528,678,979
$255.56+2.28+0.9%$255.52$257.55$254.006,548,000
$253.28-0.63-0.2%$257.11$262.45$252.629,274,700
$253.91+5.30+2.1%$249.10$253.94$248.509,662,000
$248.61-15.12-5.7%$254.56$256.18$245.1716,647,100
$263.73+2.29+0.9%$261.60$264.39$260.375,902,500
$261.44+4.96+1.9%$255.09$261.61$254.995,726,000
$256.48-1.97-0.8%$256.22$257.80$251.956,172,800
$258.45+3.67+1.4%$256.21$260.68$255.735,402,200
$254.78+1.85+0.7%$254.15$255.48$251.175,661,000
$252.93-3.10-1.2%$256.00$256.24$252.5110,026,800
$256.03-2.63-1.0%$259.38$259.38$255.1210,940,400
$258.66-6.08-2.3%$263.68$263.98$258.338,289,000
$264.74-2.83-1.1%$267.91$268.48$264.516,341,000
$267.57-4.38-1.6%$269.11$271.89$265.595,620,500
$271.95+0.73+0.3%$270.17$273.78$269.277,185,600
$271.22+0.54+0.2%$271.70$272.25$269.264,085,700
$270.68+1.51+0.6%$269.52$275.23$269.016,320,600
$269.17-0.020.0%$269.47$272.14$266.506,632,700
$269.19-0.28-0.1%$267.51$270.10$265.045,680,700
$269.47-0.52-0.2%$271.74$273.73$268.504,485,300
$269.99-0.23-0.1%$269.45$272.11$267.2016,428,400
$270.22+2.94+1.1%$268.00$270.87$267.116,568,800
$267.28+0.080.0%$266.81$268.65$266.304,887,300
$267.20+0.88+0.3%$265.81$267.20$260.685,283,500
$266.32+0.74+0.3%$271.00$271.55$266.194,740,800
$265.58-0.77-0.3%$268.03$270.40$265.254,701,200
$266.35-0.73-0.3%$270.21$271.27$265.724,929,500
$267.08-2.04-0.8%$268.51$270.10$266.736,124,600
$269.12-6.11-2.2%$271.28$271.99$266.888,084,700
$275.23-3.20-1.1%$275.13$277.80$274.754,320,100
$278.43+3.22+1.2%$277.32$278.89$273.165,940,300
$275.21+4.02+1.5%$274.74$281.07$273.537,910,600
$271.19+5.34+2.0%$270.83$271.91$267.026,033,600
$265.85-2.19-0.8%$267.13$267.77$265.177,900,100
$268.04+2.27+0.9%$265.78$268.38$264.275,765,600
$265.77-4.23-1.6%$268.45$268.45$263.837,306,200
$270.00-3.14-1.1%$271.97$272.91$269.557,214,100
$273.14+0.100.0%$271.00$273.80$270.184,687,000
$273.04+2.80+1.0%$269.74$273.98$268.575,436,100
$270.24+2.87+1.1%$267.83$272.66$267.006,186,800
$267.37-6.04-2.2%$273.40$273.40$267.376,475,900

Splits

6 splits since 1970 · NYSE:JNJ · every price before a split is adjusted for it

DayRatioWhat
2-for-1Split
2-for-1Split
2-for-1Split
2-for-1Split
3-for-1Split
3-for-1Split
Ticker
BVC:JNJ
Asset type
Stock
Sector
Health care
Industry
Pharmaceuticals
Exchange
BVC
Currency
COP

What changed lately

Latest news

All Johnson & Johnson news

Johnson & Johnson on 6ix

Sector
Health care
Industry
Pharmaceuticals
News releases
186 in the last 12 months · 208 in all · newest Nov 20, 2026 · oldest 2025
Calls
31 calls with a replay · 31 with a transcript · latest Oct 13, 2026
Decks
69 decks · latest Oct 13, 2026

Where Johnson & Johnson is listed

ListingExchangeCountryCurrency
NYSE:JNJ · Home listingNYSEUnited StatesUSD
gettex:JNJgettexGermanyEUR
BCBA:JNJBCBAArgentinaARS
Xetra:JNJXetraGermanyEUR
B3:JNJB34B3BrazilBRL
Tradegate:JNJTradegateGermanyEUR
SET:JNJ03SETThailandTHB
BCBA:JNJDBCBAArgentinaUSD
TSX:JNJTSXCanadaCAD
LS Exchange:853260LS ExchangeGermanyEUR
BMV:JNJBMVMexicoMXN
Cboe Canada:JNJCboe CanadaCanadaCAD
BVC:JNJ · This pageBVCColombiaCOP
Milan:1JNJMilanItalyEUR
Lang & Schwarz:853260Lang & SchwarzGermanyEUR
Frankfurt:JNJFrankfurtGermanyEUR
Munich:JNJMunichGermanyEUR
Turquoise:JNJNTurquoiseUnited KingdomUSD
Stuttgart:JNJStuttgartGermanyEUR
LSE:0R34LSEUnited KingdomUSD
EUROTLX:4JNJEUROTLXItalyEUR
VIE:JNJViennaAustriaEUR
BOATS:JNJBOATSUnited StatesUSD
BCBA:JNJCBCBAArgentinaUSD
BCS:JNJCLBCSChileCLP
SIX Swiss:JNJ.USDSIX SwissSwitzerlandUSD
Hamburg:JNJHamburgGermanyEUR
Hanover:JNJHanoverGermanyEUR
BIVA:JNJBIVAMexicoMXN
BCS:JNJBCSChileUSD
Dusseldorf:JNJDusseldorfGermanyEUR
BX Swiss:JNJBX SwissSwitzerlandCHF
BSESOF:JNJBSESOFBulgariaEUR
SIX Swiss:JNJSIX SwissSwitzerlandCHF
BCBA:JNJ.BBCBAArgentinaARS
Aquis:JNJDAquisUnited KingdomEUR
BVL:JNJUSBVLPeruPEN
gettex:JNJ0gettexGermanyEUR
BX Swiss:JNJUSDBX SwissSwitzerlandUSD
Aquis:JNJDAquisUnited KingdomEUR
Dusseldorf:JNJ0DusseldorfGermanyEUR
Frankfurt:JNJ0FrankfurtGermanyEUR
Lang & Schwarz:A3ET7SLang & SchwarzGermanyEUR
LS Exchange:A3ET7SLS ExchangeGermanyEUR
Munich:JNJ0MunichGermanyEUR
BCBA:JNJ.CIBCBAArgentinaARS

Valuation

P/E 40.5× against a median of 28.8×: 8th lowest of 11 Pharmaceuticals companies shown. Statements: 4 quarters to Sep 27, 2026 · price Nov 20, 2026

Enterprise value
$678.5B USD
P/E
40.5×
EV/sales
6.8×
EV/EBITDA
No depreciation figure on 6ix yet
Price/book
8.0×
Gross margin
67.6%
Operating margin
Not reported
Net margin
16.2%
Debt to equity
0.6×
Beta vs S&P 500
-0.02

Pharmaceuticals: the 10 companies nearest in size, of 492 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Johnson & Johnson · NYSE:JNJUS$651.1BUS$678.5B40.5×6.8×n/a8.0×16.2%0.6×-0.02
Eli Lilly and Company · NYSE:LLYUS$1.27TUS$1.31T46.0×15.1×n/a31.5×31.9%1.2×0.34
AbbVie Inc. · NYSE:ABBVUS$505.9BUS$503.8B48.9×7.6×n/an/a15.7%n/a0.00
Merck & Company, Inc. · NYSE:MRKUS$329.7BUS$373.8B134×5.5×n/a7.3×3.6%1.2×0.28
Novartis AG · SIX:NOVNUS$287.4BUS$304.7B20.6×n/an/a6.2×n/a0.6×n/a
AstraZeneca PLC · LSE:AZNUS$272.1BUS$298.0B24.6×4.8×14.1×5.3×17.7%0.7×n/a
Pfizer, Inc. · NYSE:PFEUS$156.2BUS$207.8B38.7×3.3×9.6×1.8×6.3%0.7×0.29
Vertex Pharmaceuticals Incorporated · NASDAQ:VRTXUS$130.6BUS$128.8B32.8×9.9×28.4×6.3×30.7%0.2×0.47
Novo Nordisk A/S Class B · OMXCOP:NOVO_BUS$129.4BUS$142.3B7.8×2.9×5.5×4.0×33.9%0.6×n/a
Bristol-Myers Squibb Company · NYSE:BMYUS$120.2BUS$151.3B13.0×3.0×n/a5.1×18.5%1.9×0.26
Sanofi SA · EURONEXT:SANUS$111.7BUS$126.9B14.6×2.3×4.7×1.4×13.9%0.3×n/a
Median of the othersUS$214.1BUS$252.9B28.8×4.8×9.6×5.3×17.7%0.7×0.29

Forecasts

11 strong buy · 5 buy · 6 hold · 1 strong sell · Analysts' consensus from EODHD, read Nov 16, 2026. Not 6ix's view and not investment advice.

Price target
279.41 USD · Analysts' mean
EPS, year to Dec 2026
11.12 · 21 analysts
Revenue, year to Dec 2026
101.2B · 21 analysts

Team and board

Officers

OfficerRole
Joaquin DuatoChairman and Chief Executive Officer
Joseph J. WolkExecutive Vice President, Chief Financial Officer
Paula A. JohnsonPresident, Wellesley College
Elizabeth ForminardExecutive Vice President, Chief Legal Officer
Ryan KoorsVice President, Investor Relations
James SwansonExecutive Vice President, Chief Information Officer
John C. ReedExecutive Vice President, Innovative Medicine, R&D
Kathryn E. WengelExecutive Vice President, Chief Technical Operations and Risk Officer
Kristen MulhollandExecutive Vice President, Chief Human Resources Officer
Tim SchmidExecutive Vice President, Worldwide Chairman, MedTech
Tom CavanaughExecutive Vice President, Worldwide Chairman, Innovative Medicine
Vanessa BroadhurstExecutive Vice President, Global Corporate Affairs
Mark B. McClellanDirector, Duke-Robert J. Margolis, MD, Center for Health Policy; Margolis Professor of Business, Medicine and Policy, Duke University

Board

DirectorRole
Joaquin DuatoChairman and Chief Executive Officer

Events

Calls

CallWhenStatus
Johnson & Johnson (NYSE:JNJ) Q3 2026 Earnings CallTue, Oct 13, 2026 · 8:30 AM ETReplay
Johnson & Johnson (NYSE:JNJ) Q2 2026 Earnings CallWed, Jul 15, 2026 · 8:30 AM ETReplay
Johnson & Johnson (NYSE:JNJ) Q1 2026 Earnings CallTue, Apr 14, 2026 · 8:30 AM ETReplay
Johnson & Johnson (NYSE:JNJ) Q4 2025 Earnings CallWed, Jan 21, 2026 · 8:30 AM ETReplay
Johnson & Johnson (NYSE:JNJ) Q3 2025 Earnings CallTue, Oct 14, 2025 · 8:30 AM ETReplay
Johnson & Johnson (NYSE:JNJ) Q2 2025 Earnings CallWed, Jul 16, 2025 · 8:30 AM ETReplay
Johnson & Johnson (NYSE:JNJ) Q1 2025 Earnings CallTue, Apr 15, 2025 · 8:30 AM ETReplay
Johnson & Johnson (NYSE:JNJ) Q4 2024 Earnings CallWed, Jan 22, 2025 · 8:00 AM ETReplay
Johnson & Johnson (NYSE:JNJ) Q3 2024 Earnings CallTue, Oct 15, 2024 · 8:30 AM ETReplay
Johnson & Johnson (NYSE:JNJ) Q2 2024 Earnings CallWed, Jul 17, 2024 · 8:30 AM ETReplay
All 31 calls
CallWhenStatus
Johnson & Johnson (NYSE:JNJ) Q1 2024 Earnings CallTue, Apr 16, 2024 · 8:30 AM ETReplay
Johnson & Johnson (NYSE:JNJ) Q4 2023 Earnings CallTue, Jan 23, 2024 · 8:30 AM ETReplay
Johnson & Johnson (NYSE:JNJ) Q3 2023 Earnings CallTue, Oct 17, 2023 · 8:30 AM ETReplay
Johnson & Johnson (NYSE:JNJ) Q2 2023 Earnings CallThu, Jul 20, 2023 · 8:30 AM ETReplay
Johnson & Johnson (NYSE:JNJ) Q1 2023 Earnings CallTue, Apr 18, 2023 · 8:30 AM ETReplay
Johnson & Johnson (NYSE:JNJ) Q3 2022 Earnings CallTue, Oct 18, 2022 · 8:30 AM ETReplay
Johnson & Johnson (NYSE:JNJ) Q2 2022 Earnings CallTue, Jul 19, 2022 · 8:30 AM ETReplay
Johnson & Johnson (NYSE:JNJ) Q1 2022 Earnings CallTue, Apr 19, 2022 · 8:30 AM ETReplay
Johnson & Johnson (NYSE:JNJ) Q4 2021 Earnings CallTue, Jan 25, 2022 · 8:30 AM ETReplay
Johnson & Johnson (NYSE:JNJ) Q3 2021 Earnings CallTue, Oct 19, 2021 · 8:30 AM ETReplay
Johnson & Johnson (NYSE:JNJ) Q2 2021 Earnings CallWed, Aug 04, 2021 · 8:30 AM ETReplay
Johnson & Johnson (NYSE:JNJ) Q1 2021 Earnings CallTue, Apr 20, 2021 · 8:30 AM ETReplay
Johnson & Johnson (NYSE:JNJ) Q4 2020 Earnings CallTue, Jan 26, 2021 · 8:30 AM ETReplay
Johnson & Johnson (NYSE:JNJ) Q3 2020 Earnings CallTue, Oct 13, 2020 · 8:30 AM ETReplay
Johnson & Johnson (NYSE:JNJ) Q2 2020 Earnings CallThu, Jul 16, 2020 · 8:00 AM ETReplay
Johnson & Johnson (NYSE:JNJ) Q1 2020 Earnings CallTue, Apr 14, 2020 · 8:30 PM ETReplay
Johnson & Johnson (NYSE:JNJ) Q4 2019 Earnings CallWed, Jan 22, 2020 · 8:30 AM ETReplay
Johnson & Johnson (NYSE:JNJ) Q3 2019 Earnings CallTue, Oct 15, 2019 · 8:30 AM ETReplay
Johnson & Johnson (NYSE:JNJ) Q2 2019 Earnings CallTue, Jul 16, 2019 · 8:30 AM ETReplay
Johnson & Johnson (NYSE:JNJ) Q1 2019 Earnings CallTue, Apr 16, 2019 · 8:30 AM ETReplay
Johnson & Johnson (NYSE:JNJ) Q4 2018 Earnings CallTue, Jan 22, 2019 · 8:30 AM ETReplay

Results days

QuarterResultsShare move
Q3 2026Oct 13, 2026 · Before open−5.7%
Q2 2026Jul 15, 2026 · Before open−2.7%
Q1 2026Apr 14, 2026 · Before open+0.9%
Q4 2025Jan 21, 2026 · Before open−0.1%
Q3 2025Oct 14, 2025 · Before open−0.0%
Q2 2025Jul 16, 2025 · Before open+6.2%
Q1 2025Apr 15, 2025 · Before open−0.5%
Q4 2024Jan 22, 2025 · Before open−1.9%
Q3 2024Oct 15, 2024 · Before open+1.6%
Q2 2024Jul 17, 2024 · Before open+3.7%
All 20 quarters
QuarterResultsShare move
Q1 2024Apr 16, 2024 · Before open−2.1%
Q4 2023Jan 23, 2024 · Before open−1.6%
Q3 2023Oct 17, 2023 · Before open−0.9%
Q2 2023Jul 20, 2023 · Before open+6.1%
Q1 2023Apr 18, 2023 · Before open−2.8%
Q4 2022Jan 24, 2023 · Before open0.0%
Q3 2022Oct 18, 2022 · Before open−0.3%
Q2 2022Jul 19, 2022 · Before open−1.5%
Q1 2022Apr 19, 2022 · Before open+3.0%
Q4 2021Jan 25, 2022 · Before open+2.9%

Open Events

Decks

DeckKindSlidesDate
Q3 2026 Earnings PresentationEarnings27 slidesOct 13, 2026
Q2 2026 Earnings PresentationEarnings24 slidesJul 15, 2026
Q1 2026 Earnings PresentationEarnings28 slidesApr 14, 2026
Q4 2025 Earnings PresentationEarnings33 slidesJan 21, 2026
Q3 2025 Earnings PresentationEarnings26 slidesOct 14, 2025
Q2 2025 Earnings PresentationEarnings25 slidesJul 16, 2025
Fact Sheet (July 2025)Fact sheet2 slidesJuly 2025
Q1 2025 Earnings PresentationEarnings32 slidesApr 15, 2025
Fact Sheet (April 2025)Fact sheet2 slidesApril 2025
Fact Sheet (2025)Fact sheet2 slides2025
Show 50 decks
DeckKindSlidesDate
Q3 2024 Earnings PresentationEarnings23 slidesOct 15, 2024
Q2 2024 Earnings PresentationEarnings23 slidesJul 17, 2024
Fact Sheet (2024)Fact sheet2 slidesJul 11, 2024
Fact Sheet (July 2024)Fact sheet3 slidesJuly 2024
Corporate Update (May 2024)Corporate update12 slidesMay 1, 2024
Q1 2024 Earnings PresentationEarnings20 slidesApr 16, 2024
Q1 2024 Earnings PresentationEarnings31 slidesApr 16, 2024
Shockwave Medical — Merger or Acquisition (April 2024)Merger or acquisition21 slidesApr 5, 2024
Q4 2023 Earnings PresentationEarnings33 slidesJan 23, 2024
Investor Day (December 2023)Investor day36 slidesDec 5, 2023
Investor Day (December 2023)Investor day88 slidesDec 5, 2023
Investor Day (December 2023)Investor day69 slidesDec 5, 2023
Investor Day (December 2023)Investor day13 slidesDec 5, 2023
Investor Day (December 2023)Investor day13 slidesDec 5, 2023
Q3 2023 Earnings PresentationEarnings21 slidesOct 17, 2023
Corporate Update (August 2023)Corporate update11 slidesAug 30, 2023
Merger or Acquisition (July 2023)Merger or acquisition35 slidesJul 25, 2023
Q2 2023 Earnings PresentationEarnings30 slidesJul 20, 2023
Fact Sheet (July 2023)Fact sheet2 slidesJul 5, 2023
Q1 2023 Earnings PresentationEarnings20 slidesApr 18, 2023
Fact Sheet (March 2023)Fact sheet2 slidesMarch 2023
Fact Sheet (March 2023)Fact sheet2 slidesMarch 2023
Fact Sheet (March 2023)Fact sheet2 slidesMarch 2023
Fact Sheet (March 2023)Fact sheet2 slidesMarch 2023
Fact Sheet (March 2023)Fact sheet4 slidesMarch 2023
Fact Sheet (March 2023)Fact sheet2 slidesMarch 2023
Q4 2022 Earnings PresentationEarnings40 slidesJan 24, 2023
Technical Presentation (January 2023)Technical34 slidesJanuary 2023
Merger or Acquisition (November 2022)Merger or acquisition22 slidesNov 1, 2022
Q3 2022 Earnings PresentationEarnings20 slidesOct 18, 2022
Q2 2022 Earnings PresentationEarnings27 slidesJul 19, 2022
Fact Sheet (June 2022)Fact sheet2 slidesJune 2022
Fact Sheet (May 2022)Fact sheet4 slidesMay 27, 2022
Fact Sheet (2022)Fact sheet2 slidesMay 12, 2022
Q1 2022 Earnings PresentationEarnings19 slidesApr 19, 2022
Q4 2021 Earnings PresentationEarnings33 slidesJan 25, 2022
Fact Sheet (2022)Fact sheet2 slides2022
Technical Presentation (December 2021)Technical5 slidesDec 16, 2021
Q3 2021 Earnings PresentationEarnings19 slidesOct 19, 2021
nh4h pitch deck slide template38 slidesSeptember 2021

This page holds 50 of 69 decks. Open Decks

Open Decks

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue94.2B88.8B85.2B80.0B78.7B82.6B82.1B81.6B76.5B71.9B
Cost of revenue30.3B27.5B26.6B24.6B23.4B28.4B27.6B27.1B25.4B21.8B
Gross profit63.9B61.4B58.6B55.4B55.3B54.2B54.5B54.5B51.0B50.1B
Research and development109.0M1.84B483.0M0012.2B11.4B10.8B10.6B9.14B
Selling, general and administrative23.7B22.9B21.5B20.2B20.1B22.1B22.2B22.5B21.5B20.1B
Depreciation and amortization7.50B7.34B7.49B6.97B7.39B7.23B7.01B6.93B5.64B3.75B
Interest expense971.0M755.0M772.0M276.0M183.0M201.0M318.0M1.00B934.0M726.0M
Income before tax32.6B16.7B15.1B19.4B19.2B16.5B17.3B18.0B17.7B19.8B
Income tax5.78B2.62B1.74B2.99B1.38B1.78B2.21B2.70B16.4B3.26B
Net income26.8B14.1B35.2B17.9B20.9B14.7B15.1B15.3B1.30B16.5B
Earnings per share, basic11.135.8413.886.837.935.595.725.700.486.04
Earnings per share, diluted11.035.7913.726.737.815.515.635.610.475.93

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents19.7B24.1B21.9B12.9B14.5B14.0B17.3B18.1B17.8B19.0B
Short-term investments393.0M417.0M1.07B9.39B17.1B11.2B1.98B1.58B472.0M22.9B
Receivables17.2B14.8B14.9B14.0B15.3B13.6B14.5B14.1B13.5B11.7B
Inventory14.2B12.4B11.2B10.3B10.4B9.34B9.02B8.60B8.77B8.14B
Current assets55.6B55.9B53.5B55.3B61.0B51.2B45.3B46.0B43.1B65.0B
Property, plant and equipment23.2B20.5B19.9B18.0B19.0B18.8B17.7B17.0B17.0B15.9B
Goodwill48.8B44.2B36.6B36.0B25.4B36.4B33.6B30.5B31.9B22.8B
Total assets199.2B180.1B167.6B187.4B182.0B174.9B157.7B153.0B157.3B141.2B
Accounts payable12.0B10.3B9.63B9.89B11.1B9.51B8.54B7.54B7.31B6.92B
Current liabilities54.1B50.3B46.3B55.8B45.2B42.5B36.0B31.2B30.5B26.3B
Long-term debt39.4B30.7B25.9B26.9B30.0B32.6B26.5B27.7B30.7B22.4B
Total debt49.9B38.4B30.8B41.2B35.9B37.1B27.7B33.1B36.1B28.8B
Total liabilities117.7B108.6B98.8B110.6B108.0B111.6B98.3B93.2B97.1B70.8B
Shareholders' equity81.5B71.5B68.8B76.8B74.0B63.3B59.5B59.8B60.2B70.4B
Shares outstanding2.41B2.41B2.41B2.41B2.41B2.41B2.60B2.63B2.63B2.63B

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations24.5B24.3B22.8B21.2B23.4B23.5B23.4B22.2B21.1B18.8B
Capital spending-4.83B-4.42B-4.54B-4.01B-3.65B-3.35B-3.50B-3.67B-3.28B-3.23B
Free cash flow19.7B19.8B18.2B17.2B19.8B20.2B19.9B18.5B17.8B15.5B
Cash from investing-23.6B-18.6B878.0M-12.4B-8.68B-20.8B-6.19B-3.17B-14.9B-4.76B
Cash from financing-5.54B-3.13B-15.8B-8.87B-14.0B-6.12B-18.0B-18.5B-7.67B-8.55B
Share buybacks-5.95B-2.43B-5.05B-6.04B-3.46B-3.22B-6.75B-5.87B-6.36B-8.98B
Change in cash-4.40B2.25B7.73B-360.0M502.0M-3.32B-802.0M283.0M-1.15B5.24B

Open Financials

Filings

FilingDateTypeFiled with
4 · Change in ownershipNov 13, 2026Insider tradeSEC
144 · Notice of proposed saleNov 12, 2026Other filingsSEC
13F-HR · Fund holdings reportOct 26, 2026Fund holdings reportSEC
10-Q · Quarterly reportOct 21, 2026Quarterly reportSEC
8-K · Current reportOct 13, 2026ResultsSEC
4 · Change in ownershipSep 10, 2026Insider tradeSEC
4 · Change in ownershipSep 10, 2026Insider tradeSEC
4 · Change in ownershipSep 10, 2026Insider tradeSEC
4 · Change in ownershipSep 4, 2026Insider tradeSEC
144 · Notice of proposed saleSep 2, 2026Other filingsSEC
Show 200 filings
FilingDateTypeFiled with
3 · Initial statement of ownershipSep 1, 2026Insider tradeSEC
4 · Change in ownershipAug 18, 2026Insider tradeSEC
144 · Notice of proposed saleAug 17, 2026Other filingsSEC
4 · Change in ownershipAug 14, 2026Insider tradeSEC
144 · Notice of proposed saleAug 13, 2026Other filingsSEC
N-PXAug 10, 2026Other filingsSEC
4 · Change in ownershipAug 7, 2026Insider tradeSEC
4 · Change in ownershipAug 7, 2026Insider tradeSEC
144 · Notice of proposed saleAug 6, 2026Other filingsSEC
13F-HR · Fund holdings reportAug 6, 2026Fund holdings reportSEC
144 · Notice of proposed saleAug 5, 2026Other filingsSEC
8-K · Current reportAug 4, 2026Management or board changeSEC
8-K · Current reportJul 29, 2026Current reportSEC
8-K · Current reportJul 27, 2026Current reportSEC
10-Q · Quarterly reportJul 23, 2026Quarterly reportSEC
4 · Change in ownershipJul 21, 2026Insider tradeSEC
144 · Notice of proposed saleJul 20, 2026Other filingsSEC
8-K · Current reportJul 15, 2026ResultsSEC
11-K · Annual report of an employee planJun 25, 2026Annual reportSEC
11-K · Annual report of an employee planJun 25, 2026Annual reportSEC
4 · Change in ownershipJun 12, 2026Insider tradeSEC
4 · Change in ownershipJun 11, 2026Insider tradeSEC
4 · Change in ownershipJun 11, 2026Insider tradeSEC
4 · Change in ownershipJun 11, 2026Insider tradeSEC
144 · Notice of proposed saleJun 11, 2026Other filingsSEC
SD · Specialized disclosureMay 27, 2026ESG reportSEC
13F-HR · Fund holdings reportMay 13, 2026Fund holdings reportSEC
4 · Change in ownershipMay 4, 2026Insider tradeSEC
SCHEDULE 13G · Big-stake noticeMay 1, 2026Big-stake noticeSEC
4 · Change in ownershipApr 27, 2026Insider tradeSEC
4 · Change in ownershipApr 27, 2026Insider tradeSEC
4 · Change in ownershipApr 27, 2026Insider tradeSEC
4 · Change in ownershipApr 27, 2026Insider tradeSEC
4 · Change in ownershipApr 27, 2026Insider tradeSEC
4 · Change in ownershipApr 27, 2026Insider tradeSEC
4 · Change in ownershipApr 27, 2026Insider tradeSEC
4 · Change in ownershipApr 27, 2026Insider tradeSEC
4 · Change in ownershipApr 27, 2026Insider tradeSEC
4 · Change in ownershipApr 27, 2026Insider tradeSEC
4 · Change in ownershipApr 27, 2026Insider tradeSEC
8-K · Current reportApr 27, 2026Meeting outcomeSEC
10-Q · Quarterly reportApr 22, 2026Quarterly reportSEC
8-K · Current reportApr 14, 2026ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedApr 13, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMar 26, 2026Big-stake noticeSEC
13F-HR/A · Fund holdings report, amendedMar 18, 2026Fund holdings reportSEC
13F-HR/A · Fund holdings report, amendedMar 18, 2026Fund holdings reportSEC
4 · Change in ownershipMar 12, 2026Insider tradeSEC
4 · Change in ownershipMar 12, 2026Insider tradeSEC
4 · Change in ownershipMar 12, 2026Insider tradeSEC
ARS · Annual report to shareholdersMar 11, 2026Annual reportSEC
DEFA14A · Additional proxy materialMar 11, 2026Meeting noticeSEC
DEF 14A · Proxy statementMar 11, 2026Meeting noticeSEC
4 · Change in ownershipMar 3, 2026Insider tradeSEC
144 · Notice of proposed saleFeb 27, 2026Other filingsSEC
4 · Change in ownershipFeb 23, 2026Insider tradeSEC
144 · Notice of proposed saleFeb 20, 2026Other filingsSEC
4 · Change in ownershipFeb 18, 2026Insider tradeSEC
4 · Change in ownershipFeb 18, 2026Insider tradeSEC
4 · Change in ownershipFeb 18, 2026Insider tradeSEC
4 · Change in ownershipFeb 18, 2026Insider tradeSEC
4 · Change in ownershipFeb 18, 2026Insider tradeSEC
4 · Change in ownershipFeb 18, 2026Insider tradeSEC
4 · Change in ownershipFeb 18, 2026Insider tradeSEC
4 · Change in ownershipFeb 18, 2026Insider tradeSEC
4 · Change in ownershipFeb 18, 2026Insider tradeSEC
4 · Change in ownershipFeb 18, 2026Insider tradeSEC
4 · Change in ownershipFeb 18, 2026Insider tradeSEC
144 · Notice of proposed saleFeb 18, 2026Other filingsSEC
144 · Notice of proposed saleFeb 17, 2026Other filingsSEC
144 · Notice of proposed saleFeb 17, 2026Other filingsSEC
144 · Notice of proposed saleFeb 17, 2026Other filingsSEC
144 · Notice of proposed saleFeb 17, 2026Other filingsSEC
13F-HR · Fund holdings reportFeb 13, 2026Fund holdings reportSEC
144 · Notice of proposed saleFeb 13, 2026Other filingsSEC
4 · Change in ownershipFeb 11, 2026Insider tradeSEC
4 · Change in ownershipFeb 11, 2026Insider tradeSEC
4 · Change in ownershipFeb 11, 2026Insider tradeSEC
4 · Change in ownershipFeb 11, 2026Insider tradeSEC
4 · Change in ownershipFeb 11, 2026Insider tradeSEC
4 · Change in ownershipFeb 11, 2026Insider tradeSEC
4 · Change in ownershipFeb 11, 2026Insider tradeSEC
4 · Change in ownershipFeb 11, 2026Insider tradeSEC
4 · Change in ownershipFeb 11, 2026Insider tradeSEC
4 · Change in ownershipFeb 11, 2026Insider tradeSEC
S-3ASR · Registration statementFeb 11, 2026Offer documentSEC
10-K · Annual reportFeb 11, 2026Annual reportSEC
4 · Change in ownershipFeb 10, 2026Insider tradeSEC
4 · Change in ownershipFeb 9, 2026Insider tradeSEC
4 · Change in ownershipFeb 9, 2026Insider tradeSEC
4 · Change in ownershipFeb 6, 2026Insider tradeSEC
144 · Notice of proposed saleFeb 5, 2026Other filingsSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 5, 2026Big-stake noticeSEC
5 · Annual statement of ownershipJan 28, 2026Insider tradeSEC
4 · Change in ownershipJan 28, 2026Insider tradeSEC
144 · Notice of proposed saleJan 26, 2026Other filingsSEC
8-K · Current reportJan 21, 2026ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedJan 12, 2026Big-stake noticeSEC
4/A · Change in ownership, amendedJan 8, 2026Insider tradeSEC
4 · Change in ownershipDec 11, 2025Insider tradeSEC
4 · Change in ownershipDec 11, 2025Insider tradeSEC
4 · Change in ownershipDec 11, 2025Insider tradeSEC
4 · Change in ownershipDec 1, 2025Insider tradeSEC
4 · Change in ownershipDec 1, 2025Insider tradeSEC
4 · Change in ownershipNov 25, 2025Insider tradeSEC
4 · Change in ownershipNov 14, 2025Insider tradeSEC
13F-HR · Fund holdings reportNov 13, 2025Fund holdings reportSEC
4 · Change in ownershipNov 10, 2025Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedOct 22, 2025Big-stake noticeSEC
10-Q · Quarterly reportOct 22, 2025Quarterly reportSEC
4 · Change in ownershipOct 20, 2025Insider tradeSEC
144 · Notice of proposed saleOct 17, 2025Other filingsSEC
8-K · Current reportOct 14, 2025ResultsSEC
3 · Initial statement of ownershipSep 15, 2025Insider tradeSEC
4 · Change in ownershipSep 11, 2025Insider tradeSEC
4 · Change in ownershipSep 11, 2025Insider tradeSEC
4 · Change in ownershipSep 11, 2025Insider tradeSEC
8-K · Current reportSep 8, 2025Management or board changeSEC
4 · Change in ownershipSep 5, 2025Insider tradeSEC
144 · Notice of proposed saleSep 4, 2025Other filingsSEC
4 · Change in ownershipSep 3, 2025Insider tradeSEC
144 · Notice of proposed saleAug 29, 2025Other filingsSEC
N-PXAug 26, 2025Other filingsSEC
4 · Change in ownershipAug 25, 2025Insider tradeSEC
144 · Notice of proposed saleAug 22, 2025Other filingsSEC
4 · Change in ownershipAug 18, 2025Insider tradeSEC
144 · Notice of proposed saleAug 15, 2025Other filingsSEC
10-Q · Quarterly reportJul 24, 2025Quarterly reportSEC
13F-HR · Fund holdings reportJul 22, 2025Fund holdings reportSEC
4 · Change in ownershipJul 18, 2025Insider tradeSEC
144 · Notice of proposed saleJul 17, 2025Other filingsSEC
8-K · Current reportJul 16, 2025ResultsSEC
3 · Initial statement of ownershipJul 8, 2025Insider tradeSEC
11-K · Annual report of an employee planJun 23, 2025Annual reportSEC
11-K · Annual report of an employee planJun 23, 2025Annual reportSEC
4 · Change in ownershipJun 12, 2025Insider tradeSEC
4 · Change in ownershipJun 12, 2025Insider tradeSEC
8-K · Current reportJun 10, 2025Management or board changeSEC
SD · Specialized disclosureMay 28, 2025ESG reportSEC
13F-HR · Fund holdings reportMay 7, 2025Fund holdings reportSEC
4 · Change in ownershipMay 5, 2025Insider tradeSEC
UPLOAD · Letter from the SECMay 2, 2025Other filingsSEC
8-K · Current reportApr 30, 2025Management or board changeSEC
4 · Change in ownershipApr 28, 2025Insider tradeSEC
4 · Change in ownershipApr 28, 2025Insider tradeSEC
4 · Change in ownershipApr 28, 2025Insider tradeSEC
4 · Change in ownershipApr 28, 2025Insider tradeSEC
4 · Change in ownershipApr 28, 2025Insider tradeSEC
4 · Change in ownershipApr 28, 2025Insider tradeSEC
4 · Change in ownershipApr 28, 2025Insider tradeSEC
4 · Change in ownershipApr 28, 2025Insider tradeSEC
4 · Change in ownershipApr 28, 2025Insider tradeSEC
10-Q · Quarterly reportApr 23, 2025Quarterly reportSEC
CORRESP · Letter to the SECApr 23, 2025Other filingsSEC
PX14A6GApr 23, 2025Other filingsSEC
UPLOAD · Letter from the SECApr 16, 2025Other filingsSEC
8-K · Current reportApr 15, 2025ResultsSEC
8-K · Current reportApr 3, 2025Current reportSEC
PX14A6GMar 20, 2025Other filingsSEC
4 · Change in ownershipMar 19, 2025Insider tradeSEC
DEFA14A · Additional proxy materialMar 12, 2025Meeting noticeSEC
ARS · Annual report to shareholdersMar 12, 2025Annual reportSEC
DEF 14A · Proxy statementMar 12, 2025Meeting noticeSEC
DFAN14AMar 7, 2025Other filingsSEC
4 · Change in ownershipMar 6, 2025Insider tradeSEC
4 · Change in ownershipMar 6, 2025Insider tradeSEC
5 · Annual statement of ownershipFeb 28, 2025Insider tradeSEC
CERT · Exchange's certificate of listingFeb 28, 2025Other filingsSEC
4 · Change in ownershipFeb 26, 2025Insider tradeSEC
8-A12B · Registration of shares for listing on an exchangeFeb 26, 2025Other filingsSEC
8-K · Current reportFeb 26, 2025Current reportSEC
DFAN14AFeb 25, 2025Other filingsSEC
144 · Notice of proposed saleFeb 25, 2025Other filingsSEC
424B2 · ProspectusFeb 21, 2025Offer documentSEC
8-K · Current reportFeb 20, 2025Current reportSEC
4 · Change in ownershipFeb 19, 2025Insider tradeSEC
4 · Change in ownershipFeb 19, 2025Insider tradeSEC
4 · Change in ownershipFeb 19, 2025Insider tradeSEC
4 · Change in ownershipFeb 19, 2025Insider tradeSEC
4 · Change in ownershipFeb 19, 2025Insider tradeSEC
4 · Change in ownershipFeb 19, 2025Insider tradeSEC
4 · Change in ownershipFeb 19, 2025Insider tradeSEC
4 · Change in ownershipFeb 19, 2025Insider tradeSEC
4 · Change in ownershipFeb 19, 2025Insider tradeSEC
4 · Change in ownershipFeb 19, 2025Insider tradeSEC
4 · Change in ownershipFeb 19, 2025Insider tradeSEC
424B2 · ProspectusFeb 19, 2025Offer documentSEC
FWP · Free writing prospectusFeb 19, 2025Offer documentSEC
424B5 · ProspectusFeb 19, 2025Offer documentSEC
4 · Change in ownershipFeb 18, 2025Insider tradeSEC

This page holds 200 of 1,000 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Johnson & Johnson’s releases · as of Oct 15, 2026

Common shares
2,407,310,266
Fully diluted
2,407,310,266

Fully diluted

LineSharesAs of
Common shares2,407,310,266Oct 15, 2026

Share count over time

CountShares
Oct 15, 20262,407,310,266

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueAs of
Vanguard249M10.4%US$66BSep 30, 2026
BlackRock210M8.7%US$55.5BSep 30, 2026
State Street134M5.6%US$35.5BSep 30, 2026
Geode Capital65.5M2.7%US$17.3BSep 30, 2026
JPMorgan61.8M2.6%US$16.5BSep 30, 2026
Morgan Stanley44.7M1.9%US$11.8BSep 30, 2026
UBS34.9M1.4%US$9.24BSep 30, 2026
Capital Group33.9M1.4%US$8.97BSep 30, 2026
State Farm Mutual Automobile Insurance Co31.6M1.3%US$8.36BSep 30, 2026
Northern Trust28.2M1.2%US$7.46BSep 30, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
Bank of America22.8M0.95%US$6.03BSep 30, 2026
T. Rowe Price22M0.91%US$5.82BSep 30, 2026
BNY21.6M0.90%US$5.71BSep 30, 2026
Legal & General19.2M0.80%US$5.08BSep 30, 2026
Schwab19M0.79%US$5.04BSep 30, 2026
Wellington19M0.79%US$5.02BSep 30, 2026
Fidelity18.7M0.78%US$4.94BSep 30, 2026
Wells Fargo17.3M0.72%US$4.58BSep 30, 2026
Goldman Sachs17M0.71%US$4.5BSep 30, 2026
Franklin Templeton15.9M0.66%US$4.35BSep 30, 2026
RBC15.3M0.64%US$4.05BSep 30, 2026
Dimensional15M0.62%US$3.97BSep 30, 2026
Invesco15M0.62%US$3.97BSep 30, 2026
Fisher Asset Management, LLC14.8M0.62%US$3.93BSep 30, 2026
DWS14M0.58%US$3.7BSep 30, 2026
Nuveen13.9M0.58%US$3.68BSep 30, 2026
Ameriprise13.4M0.56%US$3.56BSep 30, 2026
Amundi12M0.50%US$3.19BSep 30, 2026
Raymond James Financial Inc10.4M0.43%US$2.76BSep 30, 2026
HighTower Advisors, LLC9.85M0.41%US$2.61BSep 30, 2026
HSBC9.23M0.38%US$2.45BSep 30, 2026
AllianceBernstein8.22M0.34%US$2.18BSep 30, 2026
MUFG8.14M0.34%US$2.15BSep 30, 2026
Sun Life7.98M0.33%US$2.14BSep 30, 2026
Janus Henderson7.62M0.32%US$2.02BSep 30, 2026
TD7.19M0.30%US$1.91BSep 30, 2026
Grantham, Mayo, Van Otterloo & Co. LLC6.96M0.29%US$1.84BSep 30, 2026
Swiss National Bank6.58M0.27%US$1.74BSep 30, 2026
Ninety One UK Ltd6.49M0.27%US$1.72BSep 30, 2026
PNC Financial Services Group, Inc.5.67M0.24%US$1.5BSep 30, 2026
California Public Employees Retirement System5.64M0.23%US$1.49BSep 30, 2026
Sumitomo Mitsui Trust Group, Inc.5.48M0.23%US$1.45BSep 30, 2026
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main5.26M0.22%US$1.39BSep 30, 2026
National Pension Service5.26M0.22%US$1.39BSep 30, 2026
LPL Financial LLC5.23M0.22%US$1.38BSep 30, 2026
Envestnet Asset Management Inc5.16M0.21%US$1.37BSep 30, 2026
Nordea Investment Management AB5.15M0.21%US$1.38BSep 30, 2026
CPP Investments5.11M0.21%US$1.35BSep 30, 2026
Baird Financial Group, Inc.4.76M0.20%US$1.26BSep 30, 2026
Barclays4.76M0.20%US$1.26BSep 30, 2026

This page holds 50 of 4,698 holders. Open Shareholders

Funds

HolderSharesOf the companyValueAs of
Vanguard Total Stock Market Index Fund76.4M3.2%US$19.4BJun 30, 2026
Vanguard 500 Index Fund62.4M2.6%US$15.8BJun 30, 2026
iShares Core S&P 500 ETF33.1M1.4%US$8.41BJun 30, 2026
Fidelity 500 Index Fund30.8M1.3%US$6.95BMay 31, 2026
Vanguard Value Index Fund22.9M0.95%US$5.82BJun 30, 2026
State Street(R) Health Care Select Sector SPDR(R) ETF17M0.71%US$4.32BJun 30, 2026
Vanguard Dividend Appreciation Index Fund13.6M0.57%US$3.49BJul 31, 2026
Vanguard Institutional Index Fund13.1M0.54%US$3.32BJun 30, 2026
Vanguard High Dividend Yield Index Fund9.7M0.40%US$2.49BJul 31, 2026
Washington Mutual Investors Fund9.49M0.39%US$2.43BJul 31, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
Vanguard Health Care Fund7.19M0.30%US$1.84BJul 31, 2026
Vanguard Health Care Index Fund7.14M0.30%US$1.61BMay 31, 2026
Columbia Dividend Income Fund7.11M0.30%US$1.6BMay 31, 2026
JPMorgan Large Cap Growth Fund6.79M0.28%US$1.72BJun 30, 2026
MFS Value Fund6.24M0.26%US$1.41BMay 31, 2026
Vanguard Equity Income Fund5.88M0.24%US$1.49BJun 30, 2026
State Street(R) SPDR(R) Portfolio S&P 500(R) ETF5.74M0.24%US$1.46BJun 30, 2026
iShares Russell 1000 Value ETF5.38M0.22%US$1.37BJun 30, 2026
Schwab S&P 500 Index Fund5.38M0.22%US$1.38BJul 31, 2026
iShares Core Dividend Growth ETF5.12M0.21%US$1.31BJul 31, 2026
Income Fund of America5.1M0.21%US$1.31BJul 31, 2026
Fidelity Total Market Index Fund4.56M0.19%US$1.03BMay 31, 2026
American Mutual Fund4.5M0.19%US$1.15BJul 31, 2026
JPMorgan Equity Income Fund4.24M0.18%US$1.08BJun 30, 2026
College Retirement Equities Fund - Total Global Stock Account3.79M0.16%US$963MJun 30, 2026
iShares MSCI USA Quality Factor ETF3.74M0.16%US$959MJul 31, 2026
Fidelity Series Total Market Index Fund3.68M0.15%US$829MMay 31, 2026
iShares MSCI USA Momentum Factor ETF3.49M0.15%US$895MJul 31, 2026
Invesco S&P 500 Momentum ETF3.4M0.14%US$767MMay 31, 2026
The U.S. Large Cap Value Series3.21M0.13%US$823MJul 31, 2026
T. Rowe Price Health Sciences Fund, Inc.3.12M0.13%US$792MJun 30, 2026
iShares Core S&P Total U.S. Stock Market ETF3.1M0.13%US$786MJun 30, 2026
iShares U.S. Equity Factor Rotation Active ETF3.07M0.13%US$787MJul 31, 2026
iShares S&P 500 Growth ETF3M0.12%US$761MJun 30, 2026
JPMorgan Equity Premium Income ETF2.92M0.12%US$741MJun 30, 2026
T. Rowe Price Value Fund, Inc.2.89M0.12%US$735MJun 30, 2026
Capital World Growth & Income Fund2.88M0.12%US$648MMay 31, 2026
Vanguard Large-Cap Index Fund2.81M0.12%US$714MJun 30, 2026
Franklin Rising Dividends Fund2.79M0.12%US$710MJun 30, 2026
Fidelity SAI U.S. Low Volatility Index Fund2.77M0.12%US$711MJul 31, 2026
Schwab U.S. Large-Cap ETF2.56M0.11%US$577MMay 31, 2026
Vanguard Dividend Growth Fund2.52M0.10%US$645MJul 31, 2026
BlackRock Health Sciences Opportunities Portfolio2.3M0.10%US$518MMay 29, 2026
Strategic Advisers U.S. Total Stock Fund2.28M0.09%US$515MMay 31, 2026
S&P 500 Index Master Portfolio2.2M0.09%US$559MJun 30, 2026
American Balanced Fund2.17M0.09%US$551MJun 30, 2026
State Farm Growth Fund2.13M0.09%US$540MJun 30, 2026
State Street(R) SPDR(R) Portfolio S&P 500(R) Growth ETF2.12M0.09%US$538MJun 30, 2026
GMO Quality Fund2.12M0.09%US$478MMay 31, 2026
Capital Income Builder2.11M0.09%US$540MJul 31, 2026

This page holds 50 of 1,513 holders. Open Shareholders

Insider trades

TradeTradeSharesPriceValueDate
Forminard Elizabeth
Officer: EVP, Chief Legal Officer
Sale13,072USD 284.39US$3.72MNov 12, 2026
Schmid Timothy
Officer: EVP, WW Chair, MedTech
Sale11,070USD 274.74US$3.04MSep 2, 2026
Schmid Timothy
Officer: EVP, WW Chair, MedTech
Sale22,527USD 274.74US$6.19MSep 2, 2026
Taubert Jennifer L
Officer: EVP, WWC. Innovative Medicine
Sale15,000USD 263.36US$3.95MAug 17, 2026
Duato Joaquin
Director, Officer: CEO and Chairman of the Board
Sale20,976USD 262.00US$5.5MAug 13, 2026
Duato Joaquin
Director, Officer: CEO and Chairman of the Board
Sale102,315USD 261.00US$26.7MAug 13, 2026
Forminard Elizabeth
Officer: EVP, Chief Legal Officer
Sale9,344USD 257.76US$2.41MAug 6, 2026
Forminard Elizabeth
Officer: EVP, Chief Legal Officer
Sale6,574USD 255.93US$1.68MAug 6, 2026
Duato Joaquin
Director, Officer: CEO and Chairman of the Board
Sale41,957USD 258.06US$10.8MAug 5, 2026
Duato Joaquin
Director, Officer: CEO and Chairman of the Board
Sale6,523USD 258.74US$1.69MAug 5, 2026
All 12 trades
TradeTradeSharesPriceValueDate
Broadhurst Vanessa
Officer: EVP, Global Corp Affairs
Sale23,054USD 251.27US$5.79MJul 20, 2026
Wengel Kathryn E
Officer: EVP, Chief TO and Risk Officer
Sale10,000USD 241.15US$2.41MJun 11, 2026

Big stakes

StakeStakeSharesDateFiling
Vanguard Capital Management LLC7.49%181MMar 31, 2026Schedule 13G

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Bill Weldon
Other companies: Heartflow, Inc. (Chairman of the Board of Directors · Since at least Aug 7, 2025); Exxon Mobil Corporation (Director · May 29, 2013 – May 26, 2021 · Past); Chubb Limited (Director · Apr 30, 2013 – Jan 14, 2016 · Past); CVS Health Corporation (Director · Mar 29, 2013 – Nov 17, 2022 · Past); JPMorgan Chase & Co. (Director · Sep 30, 2011 – May 20, 2019 · Past)
Director · Oct 31, 2011 – Dec 13, 2012 · Past
James Cullen
Other companies: Keysight Technologies Inc. (Director · Since at least Nov 3, 2014); Avinger Inc (Director · Jan 29, 2015 – Jan 11, 2024 · Past); NeuStar Inc (Director · Jul 1, 2006 – Aug 8, 2017 · Past); Agilent Technologies, Inc. (Director · Mar 2, 2006 – May 24, 2017 · Past); Prudential Financial, Inc. (Director · Jan 1, 2006 – May 9, 2017 · Past)
Director · Feb 13, 2006 – Feb 9, 2015 · Past
John G. Morikis
Other companies: United Parcel Service, Inc. (Director · Since at least Jun 2, 2025); Whirlpool Corporation (Director · Since at least Feb 17, 2025); General Mills, Inc. (Director · Since at least Jan 29, 2024); Sherwin-Williams Company (the) (Executive Chairman, Director · Jun 10, 2022 – Feb 18, 2025 · Past); Fortune Brands Innovations, Inc. (Director · May 3, 2022 – May 16, 2023 · Past)
Director · Since at least Sep 8, 2025
Sandra E Peterson
Other companies: Seaport Therapeutics, Inc. (Director · Since at least Apr 30, 2026); Microsoft Corp. (Director · Since at least Dec 2, 2015); Zymergen Inc (Director · Apr 21, 2021 – Oct 19, 2022 · Past); Covetrus Inc (Director · Jun 10, 2020 – Oct 13, 2022 · Past); Dun & Bradstreet Holdings Inc. (Director · Mar 29, 2007 – Sep 11, 2015 · Past)
Exec VP, Group WW Chairman · Dec 1, 2012 – Feb 12, 2018 · Past
Sherilyn McCoy
Other companies: Kimberly-Clark Corporation (Director · Since at least Sep 12, 2018); Stryker Corporation (Lead Independent Director · Since at least May 2, 2018); Certara, Inc. (Director · Dec 11, 2020 – May 18, 2021 · Past); NovoCure Limited (Director · May 31, 2018 – Jun 9, 2021 · Past); Avon Products Inc (CEO, Director · Apr 23, 2012 – Apr 23, 2017 · Past)
Member, Executive Committee · Jan 2, 2008 – Feb 9, 2012 · Past
D Scott Davis
Other companies: Honeywell Aerospace Inc (Director · Since at least Jun 29, 2026); Honeywell International Inc. (Director · Since at least Nov 10, 2015); United Parcel Service, Inc. (Director · Feb 18, 2016 – Mar 18, 2016 · Past); EndoChoice Holdings Inc (Director · Aug 14, 2015 – Nov 22, 2016 · Past)
Director · Feb 8, 2016 – Apr 25, 2024 · Past
Paula A. Johnson
Other companies: Maze Therapeutics, Inc. (Director · Since at least Aug 13, 2026); ABIOMED Inc (Director · Apr 26, 2021 – Dec 22, 2022 · Past); Eaton Vance Corp (Director · May 15, 2019 – Feb 12, 2021 · Past); West Pharmaceutical Services, Inc. (Director · May 7, 2019 – May 5, 2020 · Past)
President, Wellesley College · Since at least Feb 14, 2023
Hubert Joly
Other companies: S&P Global Inc. (Director · Since at least Jan 2, 2026); Ralph Lauren Corporation (Director · Since at least Jun 30, 2009); Best Buy Co., Inc. (Director · Sep 4, 2012 – May 28, 2020 · Past)
Director · Since at least Dec 5, 2019
Mark A. Weinberger
Other companies: JPMorgan Chase & Co. (Director · Since at least Jan 16, 2024); MetLife, Inc. (Director · Since at least Aug 21, 2019); Accelerate Acquisition Corp (Director · Mar 17, 2021 – Dec 23, 2022 · Past)
Director · Since at least Dec 5, 2019
Mark B. McClellan
Other companies: Alignment Healthcare, Inc. (Director · Since at least Mar 25, 2021); The Cigna Group (Director · Since at least Dec 1, 2018); Aviv REIT Inc (Director · Mar 25, 2013 – Apr 1, 2015 · Past)
Director, Duke-Robert J. Margolis, MD, Center for Health Policy; Margolis Professor of Business, Medicine and Policy, Duke University · Since at least Oct 15, 2013
All 38 people
PersonSeat
Nadja West
Other companies: Tempus AI, Inc. (Director · Since at least Jun 13, 2024); Tenet Healthcare Corporation (Director · Since at least Oct 8, 2019); Nucor Corporation (Director · Since at least Sep 5, 2019)
Director · Since at least Dec 3, 2020
Charles Prince
Other companies: Xerox Holdings Corporation (Director · Jul 10, 2008 – Jan 12, 2018 · Past); Citigroup, Inc. (Chairman and CEO, Director · Jan 12, 2006 – Jul 13, 2007 · Past)
Director · Feb 13, 2006 – Feb 15, 2022 · Past
Colleen A Goggins
Other companies: IQVIA Holdings, Inc. (Director · Since at least Jul 25, 2017); Bausch Health Companies Inc. (Director · May 20, 2014 – May 22, 2015 · Past)
Member, Executive Committee · Jun 29, 2007 – Jan 10, 2011 · Past
Daniel E. Pinto
Other companies: Intercontinental Exchange Inc. (Director · Since at least May 15, 2026); JPMorgan Chase & Co. (President & COO · Since at least Jul 27, 2012)
Director · Since at least Jul 1, 2025
Darius Adamczyk
Other companies: Garrett Motion Inc. (Director · Apr 30, 2021 – May 26, 2021 · Past); Honeywell International Inc. (Director · Apr 7, 2014 – Jun 7, 2024 · Past)
Director · Feb 15, 2022 – Apr 25, 2024 · Past
Gary J. Pruden
Other companies: Lantheus Holdings, Inc. (Director · Since at least Feb 26, 2018); Motus GI Holdings, Inc. (Director · Feb 13, 2018 – Mar 5, 2024 · Past)
Exec VP, WW Chair, Med Devices · Apr 28, 2016 – Feb 28, 2017 · Past
Joseph J. Wolk
Other companies: Prudential Financial, Inc. (Executive Vice President and Chief Financial Officer · Since at least Sep 30, 2025); Kenvue Inc. (Director · May 23, 2024 – May 23, 2024 · Past)
Exec VP, CFO · Since at least Feb 8, 2024
Mary C. Beckerle
Other companies: Huntsman Corporation (Director · Since at least Feb 15, 2024); Exelixis, Inc. (Director · Since at least Jan 5, 2024)
Director · Since at least Apr 25, 2024
Michael E Sneed
Other companies: Kenvue Inc. (Director · Since at least May 8, 2023); Wayfair Inc. (Director · Since at least Nov 11, 2020)
EVP, Global Corp Aff & CCO · Jul 2, 2018 – Feb 12, 2021 · Past
Michael M E Johns
Other companies: AMN Healthcare Services Inc (Director · Dec 23, 2008 – Apr 21, 2021 · Past); Genuine Parts Company (Director · Dec 31, 2005 – May 11, 2015 · Past)
Director · Feb 13, 2006 – Feb 10, 2014 · Past
Peter Fasolo
Other companies: Kenvue Inc. (Director · May 8, 2023 – May 23, 2024 · Past); HireRight Holdings Corp (Director · Oct 28, 2021 – May 25, 2023 · Past)
Exec VP, Chief HR Officer · Nov 1, 2013 – Feb 15, 2024 · Past
Eugene A. Woods
Other companies: Best Buy Co., Inc. (Director · Dec 14, 2018 – Jun 14, 2023 · Past)
Director · Since at least Nov 30, 2023
John C. Reed
Other companies: Madrigal Pharmaceuticals, Inc. (Director · Since at least Aug 11, 2026)
EVP, Innovative Medicine, R&D · Since at least Apr 3, 2023
Kathryn E. Wengel
Other companies: Labcorp Holdings Inc. (Director · Since at least Mar 25, 2021)
EVP, Chief TO and Risk Officer · Since at least Jul 2, 2018
Thibaut Mongon
Other companies: Kenvue Inc. (Chief Executive Officer, Director · May 3, 2023 – Mar 10, 2025 · Past)
Exec VP, WW Chair, Cons Health · Feb 10, 2020 – Feb 13, 2023 · Past
Vanessa Broadhurst
Other companies: Zoetis Inc. (Director · Since at least Jul 25, 2025)
Executive Vice President, Global Corporate Affairs · Since at least Feb 9, 2026
Christina ZamarroChief Financial Officer · Jun 30, 2026 – Nov 5, 2026 · Past
Elizabeth ForminardExecutive Vice President, Chief Legal Officer · Since at least Aug 7, 2026
James SwansonExecutive Vice President, Chief Information Officer · Since at least Feb 9, 2026
Jennifer L TaubertEVP, WWC. Innovative Medicine · Since at least Aug 17, 2026
Joaquin DuatoCEO and Chairman of the Board, Director · Since at least Aug 5, 2026
Kristen MulhollandExecutive Vice President, Chief Human Resources Officer · Since at least Feb 6, 2026
Marillyn A. HewsonSince at least Nov 5, 2026
Ryan KoorsVice President, Investor Relations · Since at least Apr 30, 2026
Thomas CavanaughEVP WW Chair, Innovative Med. · Since at least Sep 1, 2026
Tim SchmidExecutive Vice President, Worldwide Chairman, MedTech · Since at least Sep 4, 2026
Tom CavanaughExecutive Vice President, Worldwide Chairman, Innovative Medicine · Since at least Oct 27, 2026
William HaitEVP, Chief EI and Med Officer · Jan 3, 2022 – Feb 15, 2024 · Past

Open People

Log in to ask 6ix AI your own questions about Johnson & Johnson.